Standalone and Consolidated Audited Financial Results for the Quarter and Year ended March 31, 2026
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gaudium IVF reported strong audited results for FY2026. On a consolidated basis, revenue grew 47.5% to Rs 10,435.70 Lakhs from Rs 7,072.40 Lakhs, while profit after tax rose 27.7% to Rs 2,448.85 Lakhs from Rs 1,917.73 Lakhs. Standalone revenue grew 21.3% to Rs 7,157.85 Lakhs with PAT at Rs 2,228.77 Lakhs. The company completed its IPO in February 2026, raising Rs 9,000.08 Lakhs from a fresh issue of 11.39 million shares at Rs 79 per share. IPO proceeds remain largely unutilized (Rs 8,131.20 Lakhs pending deployment). Auditors issued an unmodified (clean) opinion on both standalone and consolidated financial statements. The company operates in the healthcare/IVF segment and listed on NSE and BSE in February 2026.
Strong revenue and profit growth, particularly on consolidated basis, along with successful IPO completion are positive signals for shareholders. The significant IPO proceeds awaiting deployment for new IVF centers could drive future growth. Clean audit opinion with no going concern issues supports financial stability.